Medicine information
Uses & overview
LOBEGLITONE 0.5 is an oral antidiabetic tablet marketed by Steris Healthcare, containing Lobeglitazone Sulfate 0.5 mg. Lobeglitazone belongs to the thiazolidinedione class of medicines and acts as a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist. It helps improve insulin sensitivity in the body, supporting blood glucose management in adults with type 2 diabetes mellitus. Lobeglitazone may be prescribed when a healthcare professional determines that this treatment is appropriate for an individual's diabetes management plan. It works by improving the body's response to insulin and may help support glycaemic control alongside a balanced diet, regular physical activity, and routine blood glucose monitoring. The suitability of LOBEGLITONE 0.5 depends on the patient's medical history, cardiovascular health, liver function, existing medicines, and response to treatment. It should be used only under the supervision of a qualified healthcare professional.
How to use
Take LOBEGLITONE 0.5 exactly as prescribed by your doctor. Follow the dosage and administration instructions provided by your healthcare professional and the approved product information. Take the tablet with water as directed. Do not change the dose or discontinue treatment without consulting your doctor. Continue following your recommended diet and exercise plan, and monitor blood glucose levels as advised. Inform your healthcare professional about all medicines and supplements you take, particularly other antidiabetic medicines. Attend recommended follow-up appointments to monitor your blood glucose levels and overall response to treatment.
Storage
Store LOBEGLITONE 0.5 according to the instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children. Do not use the tablets after their expiry date. Dispose of unused or expired medicine responsibly according to local pharmaceutical disposal guidance.
